MELISSA BROWN: Open Payments
NPI 1568178713 · GREENVILLE, SC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$12,187 in 128 payments from 18 companies in 2025. Trend: 2023 $986 · 2024 $2,389 · 2025 $12,187
Speaker / faculty: $5,000Consulting: $4,000Food & beverage: $2,876Travel & lodging: $310
| Company | Payments | Amount |
|---|---|---|
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 41 | $8,929 |
| Neurocrine BioSciences, Inc. | 6 | $1,708 |
| Otsuka America Pharmaceutical, Inc. | 14 | $280 |
| Vanda Pharmaceuticals Inc. | 14 | $265 |
| ABBVIE INC. | 20 | $194 |
| Axsome Therapeutics, Inc. | 5 | $188 |
| Janssen Pharmaceuticals, Inc | 5 | $177 |
| Alkermes, Inc. | 4 | $98 |
| Almatica Pharma LLC | 4 | $68 |
| Noven Therapeutics, LLC | 3 | $61 |
Products named: CAPLYTA, REXULTI, VRAYLAR, Auvelity, SPRAVATO, HETLIOZ, FANAPT, INGREZZA.
Industry payments across SC — which companies pay providers there.
